Numbers

The Numbers

QuantumScape is not a company with financial statements in the traditional sense — it is a $971M pile of cash being spent at roughly $280M a year on solid-state battery R&D, wrapped inside a $4.2B market cap. The single number that rerates or derates the stock is cash runway versus milestone timing: management now guides to runway "through the end of the decade" on the back of a restructured PowerCo deal, against cumulative operating losses of $3.6B since 2018 and share count up 128% in five years. Everything else is noise around that one trade-off.

Snapshot

Economic Shape — a Pre-Revenue Development Program

R&D climbed from $36M in 2018 to $376M in 2025 — a 10-fold ramp reflecting pilot line build-out (Raptor, Cobra, Eagle lines). SG&A has actually compressed from $142M in 2024 to $97M in 2025, evidence of the "operational streamlining" management referenced alongside the PowerCo restructuring. All of this opex lands directly in operating loss because there is no revenue offset.

The 2020 net loss of $1.68B is a non-cash warrant-revaluation artifact from the DeSPAC — operating loss that year was only $81M. The same SPAC distortion reversed in 2021 (net loss of only $46M vs operating loss of $215M). Normalized annual operating losses now cluster in the $420 to $510M range.

Cash Burn Trajectory

The important shape here: capex peaked at $159M in 2022 during pilot line installation and has fallen 77% to $36M in 2025. Operating cash burn has been flat at $240 to $275M for four consecutive years. FCF burn improved from $337M (2024) to $279M (2025) — the first year-over-year reduction in the company's history and a direct input into the runway extension.

Quarterly operating loss peaked at $134M in 2Q24 and has compressed by 19% to $109M in 1Q26. R&D spend is holding steady near $80 to $85M per quarter, which is the floor for maintaining pilot-line operations.

Balance Sheet Durability — the Cash Runway

Peak liquidity was $1.45B at end of 2021 after the DeSPAC PIPE round. Cash has drawn down $480M over four years — roughly $120M per year net of financing inflows. At the 2025 FCF burn of $279M, the $971M balance is 3.5 years of runway on pure math; management guides to "end of the decade" (through 2029 or into 2030) assuming PowerCo milestone inflows land on schedule.

The Dilution Reality

The 2018 share count of 11M is the pre-SPAC private-company baseline; the 240M jump in 2019 reflects the reverse-merger accounting. Even ignoring that, the post-SPAC period shows steady 8 to 15% annual dilution — 13.4% in 2025 alone. Cash-raising, not operating performance, is the swing variable for per-share value.

Price History — the Mean-Reversion Story

From the $132 peak on Dec 22, 2020 — within five weeks of listing — to the $3.47 nadir on April 8, 2025, QS lost 97% of its value. The 2025 PowerCo deal restructure triggered a 4x rally from the April lows to a $19 52-week high in November 2025, followed by the current pullback to $7.31 after 4Q25 results. The stock now trades roughly 94% below its all-time high and 45% below its 52-week high.

Peer Comparison — Solid-State and Advanced Battery Peers

QuantumScape is the outlier on two dimensions: zero revenue (all peers have commercial shipments) and the deepest cash position at $971M. Amprius trades at an extreme P/B of 30 on commercial revenue traction; Microvast is the only peer approaching EBITDA positive on $428M revenue. SLDP is the closest structural comp — also pre-commercial solid-state — but at 1/5 the market cap and 1/3 the cash.

Capital Formation — PowerCo Is the Swing Factor

The expanded PowerCo licensing agreement signed mid-2025 is the defining capital event of the company's post-IPO history. Key terms per management commentary:

"The PowerCo agreement now allows licensed production of up to 85 gigawatt hours of QuantumScape cells annually, including expansion beyond Volkswagen Group customers."

"We ended the quarter with $1 billion in liquidity. We now project our cash runway extends through the end of the decade, a twelve-month extension from our previous guidance of into 2029."

The monetization thesis is non-dilutive: customer development payments today, royalty streams later as PowerCo scales licensed production. Until milestone triggers hit, the company must continue bridging with ATM equity issuance — the 13.4% dilution observed in 2025 is a reasonable proxy for the annual pace if no milestones convert to cash.

What the Market Is Saying

Valuation — Book Value Is the Only Defensible Anchor

With zero revenue, zero EBITDA, and no path to GAAP earnings before 2028 earliest, traditional multiples (P/E, EV/EBITDA, P/S) are meaningless. The only anchored valuation methods are:

At the current $7.31 price, investors are paying a 3.6x premium over book and effectively $3.25B for the technology option (enterprise value net of cash). The question is whether Volkswagen's 85 GWh licensed-production commitment eventually translates to royalties that can justify that premium — or whether the equity issuance pace outruns milestone triggers.

Close

What the numbers confirm: QuantumScape is a pre-revenue cash-burn story with no operating economics to analyze. Management has converted a $3B+ cumulative R&D spend into a single strategic asset — the PowerCo licensing relationship — and has enough cash to operate through at least 2029. Quarterly losses are trending down for the first time; SG&A has compressed 32% year-over-year in 2025.

What the numbers contradict: The "massive dilution death spiral" narrative is partially wrong — while shares are up 128% in five years, the 2025 financing inflow of $313M was substantially smaller than 2021's $737M, and much of it was PowerCo non-dilutive. The enterprise value of $3.25B is also not absurd given the option value of an 85 GWh license.

What to watch: The 2026 milestone trigger schedule on PowerCo. If cash inflow converts at the pace implied by runway guidance (into 2030), dilution stops mattering. If milestones slip and the company bridges with another $300M+ ATM issuance in 2026, the 13.4% annual dilution compounds and book value per share takes another leg down. Next earnings date: April 29, 2026.